Low Racemization in Peptide Synthesis Is Not Just About Reagent Choice: Stereochemical Risk During the Activation Stage and Practical Strategies for Experimental Control

Introduction

“Racemization” in peptide synthesis is often discussed as if it were mainly a question of whether one coupling reagent is better than another. From the standpoint of reaction chemistry, however, what deserves greater caution is the period after the carboxylic acid has been activated. In many cases, loss of stereochemical integrity does not begin only after amide bond formation; it already starts during the generation, residence, and conversion of the activated intermediate. Strictly speaking, the more common problem in peptide synthesis is epimerization, in which a single stereogenic center is converted from L to D. Accordingly, the term “racemization” in this article mainly refers to this type of configurational change. This issue must be taken seriously not only because it generates by-products, but also because epimers are usually physicochemically similar to the target peptide, difficult to separate, and may further alter peptide conformation, receptor recognition, and biological activity.

This article does not focus on “which coupling reagent gives the lowest racemization,” but rather on the following three key questions.

Core Question	Key Judgment Worth Focusing On
Can low racemization be achieved mainly by “switching to a more advanced coupling reagent”?	No. The coupling reagent is only one variable. The activation mode, pre-activation time, base, temperature, protecting group, resin, and anchoring strategy can all affect the stereochemical outcome.
At what stage is stereochemical risk most concentrated?	It often concentrates in the window during which the carboxylic acid has already been activated but has not yet been efficiently trapped by the amine.
What is the truly effective control strategy?	Shorten the residence time of high-risk intermediates, minimize unnecessary base exposure, and optimize temperature, protecting groups, solid support, and loading strategy separately for sensitive residues.

1. Why Low Racemization Is a Core Quality Issue in Peptide Synthesis

In peptide synthesis, the successful formation of an amide bond does not necessarily mean that the system is sufficiently reliable. For stereochemically sensitive sequences, what truly determines method quality is often not only yield and reaction rate, but also whether stereochemistry can be retained in a stable manner. Recent reviews have regarded epimerization as one of the major side reactions in peptide synthesis that must be actively avoided, because it not only increases crude-product complexity and purification burden, but may also further affect structural characterization and subsequent biological evaluation. Since epimers are usually physicochemically similar to the target peptide and difficult to separate, stereochemical problems become a quality issue in peptide synthesis that cannot simply be postponed to downstream processing.

Accordingly, low racemization should not be understood in an oversimplified way as merely “switching to a more advanced coupling reagent.” Epimerization is intrinsically the result of multiple variables acting together: the activation pathway determines whether intermediates are more prone to configurational erosion; the type and amount of base influence the tendency toward α-deprotonation; temperature, solvent, residue structure, and side-chain protection all affect stereochemical risk; and under specific process conditions such as fragment coupling, microwave assistance, or rapid-flow synthesis, these factors may be amplified even further. In peptide synthesis, simply comparing whether a given reagent is “highly reactive” or “gives high yield” is not enough to determine whether it is truly suitable for stereochemically sensitive targets.

It is therefore helpful to narrow the analysis to several core dimensions. The factors below determine whether stereochemical risk is already amplified before bond formation takes place.

Evaluation Dimension	Question to Ask	Direct Impact on Experimental Outcome
Activation mode	After activation, does the system readily form intermediates that are more prone to configurational erosion?	Determines whether risk is amplified before bond formation
Residence time of the activated state	How long does a high-risk intermediate remain in the system?	The longer it remains, the more likely epimerization becomes
Basic environment	Do the type and amount of base promote α-H deprotonation?	Directly affects the stability of the stereogenic center
Temperature	Is elevated temperature or microwave acceleration used?	Can shorten reaction time, but may also amplify side pathways
Residue and protecting group	Are sensitive residues such as Cys, His, or Asp involved?	Determines whether residue-specific optimization is required
Solid support and loading strategy	Do the resin and anchoring mode amplify the risk at particular sensitive sites?	Especially critical for certain C-terminally sensitive residues

2. Why the Activation Stage Is Often the High-Risk Window That Should Be Checked First

2.1 Why Does the Activated State More Readily Enter Pathways That Erode Stereochemistry?

The most important chemical background to peptide epimerization is that, once the carboxylic acid has been activated, it is no longer merely an intermediate waiting for nucleophilic attack by an amine; it may also enter side pathways that are more prone to loss of stereochemical integrity. Recent reviews have summarized the representative pathways commonly discussed in peptide synthesis into two broad classes: one associated with oxazolone formation, and the other associated with deprotonation at the α-position under basic conditions followed by reprotonation. The former shows that the activated intermediate itself may enter a state that is more susceptible to configurational erosion, while the latter shows that a basic environment can directly perturb the stereogenic center. Both pathways point to the same fact: stereochemical problems often begin before the amide bond is actually formed.

2.2 Pre-Activation Prolongs Exposure to the High-Risk Activated State

This is why pre-activation is especially sensitive in many systems. For high-risk substrates, pre-activation is not merely a step intended to improve reaction efficiency; it also causes the substrate to remain longer in a high-risk state in which it is already activated and often still exposed to base. The classic study by Han, Albericio, and Barany showed that N,S-protected Cys derivatives can undergo substantial epimerization even under widely used stepwise solid-phase conditions. The same study also showed that eliminating or shortening pre-activation, reducing base exposure, and optimizing the type of base and solvent are all effective measures for controlling this problem. In other words, this type of risk does not arise only under extreme conditions; it can also occur in routine peptide synthesis workflows.

2.3 Deprotection/Coupling Cycles Under Strong Base and Heating Can Also Amplify Risk

In addition to the activation stage, the deprotection/coupling cycles in Fmoc-SPPS, especially when strong base and heating are combined, can also amplify stereochemical risk for certain residues. The study by Palasek and co-workers on microwave-enhanced Fmoc-SPPS showed that Asp, Cys, and His are all sensitive sites that require particular caution under such conditions. Lowering the coupling temperature from 80 °C to 50 °C helps limit epimerization of His and Cys. For Asp, risk in Fmoc-SPPS is often coupled with aspartimide formation and its subsequent isomerization or epimerization, so it must be evaluated together with the deprotection conditions.

The major risk sources during the activation stage and adjacent steps can be summarized as follows.

Source of Risk	When It Occurs	Nature of the Risk	Typical Direction of Control
Oxazolone-related pathway	After carboxylic acid activation and before amine attack	The intermediate enters a state more prone to configurational erosion	Shorten activation time and reduce pre-activation
α-H deprotonation	During activation or basic deprotection	Reprotonation may occur from the opposite face	Adjust the type and amount of base, and the temperature
High-temperature amplification	Under microwave or rapid heating conditions	Side pathways accelerate together with the desired reaction	Lower the temperature specifically for sensitive residues
Deprotection-associated side reactions	During Fmoc deprotection	A strongly basic environment amplifies residue sensitivity	Optimize the deprotection formulation and exposure time

2.4 Which Residues and Scenarios Require the Earliest and Strongest Preventive Attention?

When these mechanistic considerations are translated into experimental design, the first priorities for preventive control are the residues and process scenarios in which activated states or basic conditions are more likely to amplify stereochemical problems.

1. Cys is one of the most typical high-risk residues in peptide synthesis. Available studies show that even under widely used stepwise solid-phase incorporation conditions, N,S-protected Cys derivatives may still undergo significant epimerization. A routine synthetic route, therefore, does not automatically guarantee stereochemical safety.

2. His also requires special caution. The study by Torikai and co-workers showed that the extent of His epimerization is strongly influenced by the protection mode of the imidazole nitrogen. The N(π)-NAPOM protecting strategy suppressed His epimerization in both Boc and Fmoc systems, indicating that stereochemical control for His cannot be addressed only at the level of coupling reagent selection.

3. The risk associated with Asp depends more strongly on the specific process conditions. In Fmoc-SPPS, especially under microwave conditions and stronger basic deprotection conditions, Asp is often associated with aspartimide formation and the subsequent isomerization or epimerization that follows. It should therefore always be evaluated together with the deprotection conditions.

4. Beyond the residue itself, fragment coupling and rapid high-temperature processes also require priority control. In fragment coupling, the activated site is the C-terminal residue of the peptide fragment, and epimerization is markedly affected by solvent polarity and the way base participates in the system. Rapid high-temperature processes should not be simplistically understood as “faster therefore inherently lower in racemization”; only when time, temperature, and sensitive sites are optimized separately can high efficiency and stereochemical retention be achieved simultaneously. Experimental findings on His protecting-group optimization and on sensitive sites in microwave Fmoc-SPPS both support this conclusion.

To facilitate direct translation of the above considerations into experimental design, the residues and scenarios that should receive preventive attention first are summarized below.

Residue or Scenario	Characteristic Risk	Variables More Suitable for Priority Adjustment
Cys incorporation	Significant epimerization may occur even under routine stepwise incorporation conditions	Pre-activation time, base, temperature, and sulfur-protecting strategy
His incorporation	The imidazole side-chain protecting mode affects the extent of configurational erosion	Side-chain protecting group, activation window, and temperature
Asp-containing sequences	Risk increases when deprotection is coupled with related side reactions	Deprotection formulation, temperature, and residence time
Fragment coupling or high-risk C-terminal activation	Activation at the peptide C-terminus more readily leads to loss of stereochemical information	Solvent polarity, activation time, and mode of base participation
Sensitive sites under rapid high-temperature processes	Shorter reaction time does not automatically mean lower racemization	Residue-specific optimization rather than one uniform condition for the whole process

3. Experimental Control Logic for Low Racemization

As discussed above, peptide epimerization is not determined by a single reagent, but is jointly affected by the activation pathway, residence time of the activated state, base, temperature, protecting group, and, in solid-phase synthesis, loading conditions. In actual experimental troubleshooting, what matters most is first identifying which variables should be adjusted with priority. For stereochemically sensitive systems, pre-activation time, base exposure, temperature profile, side-chain protection strategy, and, when necessary, resin and anchoring mode are usually more important to examine first than simply replacing one coupling reagent with a “newer” one. In SPPS, stereochemical control for C-terminally sensitive residues also requires the resin and loading route to be included in the evaluation.

Practical Handle	Main Function	Typical Applicable Scenario
Shorten or eliminate pre-activation	Reduce the residence time of high-risk intermediates	Incorporation of sensitive residues such as Cys and His
Adjust the type and amount of base	Lower the probability of α-H deprotonation	Stereochemically sensitive substrates and basic deprotection stages
Lower the temperature specifically for sensitive residues	Limit the amplifying effect of high temperature	Microwave-assisted or rapid-heating conditions
Replace the side-chain protecting group	Reduce the tendency toward configurational erosion at the structural level	High-risk residues such as His
Choose a more suitable resin or anchoring mode	Move risk control upstream at the level of the solid support	C-terminal Cys or other sensitive C-terminal sites
Use a milder additive system	Improve the behavior of activated intermediates	Optimization of carbodiimide/Oxyma conditions
Use process control instead of crude acceleration	Shorten exposure history without blindly increasing temperature	Rapid-flow and automated synthesis

4. Several Judgment Errors Most Commonly Encountered in Low-Racemization Experiments

1) Is low racemization an intrinsic and fixed property of a particular reagent?

No. Epimerization is never a fixed label attached to a single product; it is a property of system behavior. The same coupling reagent may give completely different stereochemical outcomes under different bases, temperatures, side-chain protections, substrates, and loading conditions. Therefore, whether a system is truly “low in racemization” cannot be judged only from the reagent name; it must be judged by whether, under the actual conditions used, the substrate is allowed to remain for a prolonged period in a high-risk activated state.

2) If the process is faster, does that mean the stereochemistry is safer?

No. The value of high-efficiency processes such as microwave-assisted synthesis and rapid-flow synthesis lies in their ability to provide more precise control over time and temperature, not in any inherent immunity to epimerization. Only when sensitive residues are optimized separately can “faster” possibly be converted into “lower racemization.” If one merely raises the temperature or compresses the cycle without controlling the activation and deprotection windows, high-risk sites may still undergo significant configurational erosion.

3) If the main peak is larger and the yield is higher, does that mean the stereochemistry is fine?

No. Epimers are often physicochemically similar to the target peptide, and routine purity information is not equivalent to stereochemical information. A crude product that “appears to have been successfully made” does not mean that its stereochemistry has been preserved. For stereochemically sensitive peptides, yield, purity, and stereochemical integrity must be evaluated separately and cannot substitute for one another. A 2023 review likewise identified “how to characterize epimerization” as a question that must be addressed independently.

4) What does it mean, experimentally, to have truly evaluated low racemization?

A more reliable approach is to treat “whether epimerization has occurred” as an independent analytical task, rather than judging only from main-peak area, crude purity, or yield. For full-length peptides, one may first use a targeted HPLC or LC method to compare chromatographic changes at suspicious sites before and after condition optimization. If further confirmation of configurational retention at a given residue is needed, this can be combined with chiral derivatization-HPLC after acid hydrolysis, Marfey’s method, or other chromatographic/mass spectrometric methods suitable for amino acid enantiomer analysis. For Cys-containing systems, the literature has reported methods in which the Cys residue is first oxidized and then hydrolyzed, followed by Val-Marfey derivatization-HPLC to determine its configuration and degree of racemization. The significance of such analyses lies not in whether “the peak is larger,” but in whether targeted stereochemical analysis can demonstrate that the configuration of the residue of interest has in fact been preserved.

5. A Practical Troubleshooting Sequence

When a sequence is suspected to suffer from epimerization, a more effective approach is usually not to replace the entire system immediately, but rather to troubleshoot step by step according to the most likely sources of risk: first examine sensitive residues and the activation window; then examine the base, temperature, and deprotection conditions; and only in the relevant cases proceed further to inspect the resin and anchoring mode. This sequence is more consistent with the logic by which epimerization arises and also makes it easier to locate the problem quickly in practice.

Troubleshooting Order	Problem to Check First	Preferred Initial Action
1	Whether sensitive residues such as Cys, His, or Asp are present	First define the sensitive site(s) as separate optimization targets
2	Whether pre-activation is used and whether the time is too long	First shorten or eliminate pre-activation
3	Whether the current base is too strong or used in excess	Adjust the type and amount of base
4	Whether a uniform high-temperature condition is being used	Lower the temperature specifically for sensitive residues
5	Whether the deprotection stage is also amplifying the problem	Optimize the deprotection conditions simultaneously
6	Whether the side-chain protecting strategy is unfavorable for risk control	Reevaluate the protecting group choice
7	In SPPS involving sensitive C-terminal sites, whether the resin and anchoring mode are unfavorable for risk control	Reevaluate the resin, loading route, or anchoring strategy
8	If the result is still unsatisfactory after all the above	Only then consider changing the coupling system or process platform

6. Product Navigation Table for Low-Racemization Control in Peptide Synthesis

(Quickly locate Tables 1–4 by research or experimental task)

Current Research or Experimental Goal	Recommended Table to Consult First	Why This Table Should Be Prioritized	Suggested Related Table	Navigation Note
To establish an initial screening framework for low racemization in peptide synthesis and determine which class of conditions should be examined first	Table 2	Table 2 focuses on the classic screening axis of “activation mode + additive,” centered on DIC, DCC, and their combinations with HOBt, HOAt, Oxyma, and related additives, making it the most suitable starting point for a first-round methodological screen. EDC·HCl is better treated as an alternative carbodiimide activation system for supplementary comparison under different media or activation modes.	Then see Table 1	First define the main activation/additive route, then use Table 1 to supplement solvents, bases, and deprotection conditions; this makes it easier to establish a complete basic methodological framework.
To compare traditional carbodiimide routes with additive-assisted routes designed for lower epimerization	Table 2	Table 2 includes both classic carbodiimide routes and commonly used low-epimerization additives, making it suitable for head-to-head comparison of DIC/DCC with HOBt, HOAt, and Oxyma. If comparison of medium compatibility or alternative activation modes is also desired, EDC·HCl can be added as an auxiliary control.	Then see Table 3	Once Table 2 has already shown differences among additives, Table 3 can then be used to introduce more complete coupling systems such as HATU, COMU, and DEPBT, making it easier to judge whether “additive optimization” or “switching the coupling platform” is the more effective route.
To directly compare modern coupling systems such as HBTU, HATU, TBTU, COMU, DEPBT, PyBOP, and PyAOP	Table 3	Table 3 concentrates on uronium, phosphonium, and triazine-based coupling reagents, making it most suitable for system screening centered on reactivity, stereochemical retention, and substrate compatibility.	Then see Table 4	If the screening targets include high-risk residues such as Cys, His, or Phg, combining Table 4 will better reflect realistic research scenarios.
To study how activation-stage residence time, pre-activation, and leaving-group type affect epimerization	Table 2	Table 2 is best suited for research focused on the activation stage itself, because the products in this table directly correspond to the main axis of carbodiimide activation and additive modulation.	Then see Table 1	Beyond pre-activation time, bases and solvents also influence the result; combining Table 1 allows simultaneous optimization of the activation window together with the reaction medium and acid scavenger/base.
To establish residue-specific low-racemization conditions for high-risk residues such as Cys, His, Asp, and Phg	Table 4	Table 4 focuses on high-risk amino acid monomers and side-chain protection modes, making it the most suitable table for directly designing experiments around which residue is most sensitive and which protecting strategy is more appropriate.	Then see Table 2 or Table 3	If the emphasis is on screening combinations of “residue × activation system,” Table 2 is more suitable for building a basic additive-based route first; if complete coupling systems are to be compared, Table 3 is the better companion.
To compare how protecting strategies such as His(Boc) vs His(Trt) and Cys(Trt) vs Cys(Acm) affect low-racemization outcomes	Table 4	In Table 4, the same sensitive residue types are represented with different protection strategies, making it the most suitable table for comparing how protecting-group strategy affects stereochemical retention and downstream steps.	Then see Table 3	Differences in protecting-group strategy are usually clearer when placed within a specific coupling system, so parallel coupling screens using Table 3 are also recommended.
To optimize the Fmoc deprotection stage and reduce side reactions caused by Asp-sensitive sequences or strongly basic conditions	Table 1	Table 1 includes piperidine, piperazine, DBU, TFA, TIPS, as well as supporting components such as DMF and NMP, making it most suitable for optimization of deprotection, cleavage, and post-treatment conditions.	Then see Table 4	If the target sequence contains Asp, His, or Cys, combining the sensitive residue monomers in Table 4 will make the condition comparison more targeted.
To compare the effects of DMF, NMP, DCM, and different base combinations on coupling and deprotection performance	Table 1	The reaction media, tertiary amine bases, strong bases, and cleavage systems in Table 1 are best suited for screening along the solvent/base-condition dimension.	Then see Table 2	Once the solvent and base conditions have been defined, combining Table 2 to evaluate the response of activators and additives allows a more systematic establishment of the low-racemization process window.
To build a “traditional route vs modern low-racemization route” comparison system for methodology or process evaluation	Table 2	Table 2 is the most suitable starting point for classic carbodiimide + additive routes, making it convenient for constructing the first level of comparison between historically established conditions and modern optimized conditions.	Then see Table 3	If the comparison needs to be further extended to modern coupling systems such as HATU, COMU, DEPBT, and PyAOP, Table 3 provides a more complete extension.
To evaluate from the standpoint of final cleavage and post-treatment whether sensitive side chains remain stable and whether the cleavage stage introduces additional complexity	Table 1	The TFA, TIPS, and DCM entries in Table 1 directly correspond to the acid cleavage, scavenging, and post-treatment workflow, making this table best suited for evaluating whether terminal processing affects crude-product quality.	Then see Table 4	If the sequence contains sensitive sites such as Cys or His, combining the protected monomer sources in Table 4 helps clarify protecting-group behavior during cleavage and thereby supports condition setting.
To create a standard low-racemization screening route suitable for teaching, beginners, or general methodological development	First Table 2, then Table 1	Table 2 is convenient for first establishing the activation/additive axis, while Table 1 then supplements solvents, bases, and deprotection conditions. Together, they are best suited for building a general screening template.	Then see Table 3	After the basic template is running smoothly, the modern coupling systems in Table 3 can be included in a second round of screening to form an expandable method library.
To perform in-depth condition optimization for difficult coupling sequences or complex peptide fragments, rather than staying at the level of basic condition comparison	First Table 4, then Table 3	The difficulty usually first arises from sensitive residues or protecting strategies. Table 4 helps define the problematic substrate class first, while Table 3 then provides a wider range of coupling systems for targeted optimization.	Then see Table 1	Once the high-risk residues and coupling system have been determined, Table 1 can be used to fine-tune the base, solvent, and deprotection conditions, making it easier to refine the method into a robust one.

Table 1 | Reaction Media, Acid-Cleavage Systems, and Components for Regulating Basic Conditions

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Common polar reaction medium for solid-phase peptide synthesis	68-12-2	D119450	N,N-Dimethylformamide (DMF)	Anhydrous, ≥99.8%	A classic polar aprotic solvent commonly used in coupling, washing, and deprotection steps in Fmoc solid-phase peptide synthesis; compatible with resin swelling and the solubility of activation systems, and suitable as a foundational reaction medium for establishing low-epimerization conditions.
Main reagent for acid cleavage / global deprotection	76-05-1	T433655	Trifluoroacetic acid (TFA)	Anhydrous, ≥99%	A core reagent for final cleavage and removal of acid-labile protecting groups in solid-phase peptide synthesis, often used together with silane-based scavengers; suitable for evaluating how the cleavage stage affects side-chain protecting-group integrity and post-treatment purity.
Acid-scavenging base for coupling / non-nucleophilic tertiary amine base	7087-68-5	D109322	N,N-Diisopropylethylamine	Distilled grade, ≥99.5%	Commonly used in carbodiimide, uronium, and phosphonium coupling systems to neutralize acidic by-products and promote activation; its relatively high steric hindrance makes it suitable as a standard supporting base in routine peptide coupling.
Common polar reaction medium for solid-phase peptide synthesis	872-50-4	M103246	1-Methyl-2-pyrrolidinone	Electronic grade, ≥99.9%	A highly polar aprotic solvent similar to DMF, commonly used in coupling and deprotection steps in solid-phase peptide synthesis; suitable for comparing how different reaction media affect difficult coupling substrates and epimerization control.
Alternative base for Fmoc deprotection / component for controlling Asp-related side reactions	110-85-0	P755827	Piperazine	UltraBio™, anhydrous, ≥99%(T)	Commonly used as an alternative to, or in combination with, piperidine for deprotection; suitable for condition screening in Asp-sensitive sequences or when deprotection-related side reactions need to be reduced.
Common base for Fmoc deprotection	110-89-4	P1506301	Piperidine	AR, ≥99.5%	One of the most commonly used bases for Fmoc deprotection, featuring rapid deprotection and broad applicability; suitable for establishing standard Fmoc-SPPS deprotection procedures and for comparison with piperazine- or DBU-based systems.
Solvent for resin swelling / washing / cleavage dilution	75-09-2	D116144	Dichloromethane	AR, ≥99.5%, contains 50–150 ppm isoamylene as stabilizer	Commonly used for resin pretreatment, washing, certain protecting-group manipulations, and dilution after acid cleavage; suitable for post-treatment and scavenger screening in combination with TFA cleavage systems.
Acid-scavenging base for coupling / base for condition optimization	109-02-4	M104642	N-Methyl morpholine	≥99%(GC)	A classic tertiary amine base, often used with triazine-type coupling reagents such as DMTMM and also suitable for comparing base conditions in routine coupling systems; useful for screening coupling performance under milder basic conditions.
Strong organic base / accelerating base for deprotection	6674-22-2	D106478	1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU)	≥99%	More basic than conventional tertiary amines, DBU is commonly used to accelerate Fmoc deprotection or to establish comparison conditions with a stronger basic environment; suitable for studying how base strength affects deprotection efficiency and side reactions.
Hindered base / base for condition optimization at sensitive sites	108-75-8	T108942	2,4,6-Trimethylpyridine	≥99%	A sterically hindered aromatic tertiary amine base, often used in condition comparisons when overly strong basicity needs to be suppressed or when coupling sensitive residues is being optimized; suitable for base screening at high-risk sites.
Acid-cleavage scavenger / auxiliary reagent for deprotection	6485-79-6	T420182	Triisopropylsilane (TIPS)	≥98.5%	A commonly used carbocation scavenger in TFA cleavage systems, helping to reduce side reactions involving thiols, aryl groups, and other functionalities susceptible to acidic reactive species; suitable for optimization of final cleavage conditions in combination with TFA.

Table 2 | Classical Activators and Low-Epimerization Additives

Note: Although HOBt and HOAt are classical low-epimerization additives and remain representative in historical methodological comparisons, modern condition screening now more often prioritizes Oxyma-type additives because of the safety concerns associated with benzotriazole-based additives.

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Carbodiimide activator / in situ carboxylic acid activation reagent	693-13-0	D433332	Diisopropylcarbodiimide solution	1 M in THF	Commonly used for in situ activation of carboxylic acids together with additives such as HOBt, HOAt, and Oxyma; suitable for studying the relationship between activation-stage residence time and epimerization.
Azabenzotriazole additive / promoter for low epimerization	39968-33-7	H109328	1-Hydroxy-7-azabenzotriazole	≥99%	A classical high-activity additive commonly used with carbodiimide or phosphonium systems to improve coupling efficiency and suppress activation-stage epimerization; suitable for optimizing conditions for difficult coupling sites and high-risk substrates.
Benzotriazole additive / classical additive for suppressing epimerization	2592-95-2	H684271	1-Hydroxybenzotriazole (HOBT)	≥99%	A classical peptide-coupling additive commonly used to suppress side reactions arising from activated intermediates and improve the performance of routine carbodiimide couplings; suitable for establishing traditional low-epimerization comparison systems.
Carbodiimide activator / classical carboxylic acid activation reagent	538-75-0	D106074	N,N′-Dicyclohexylcarbodiimide	≥99%	A classical carboxylic acid activator commonly used together with HOBt or HOAt; suitable for building a traditional peptide-coupling baseline and comparing by-product handling and epimerization control.
Control-type / alternative carbodiimide activator	25952-53-8	E106172	N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride	≥98%	Commonly used for amide bond formation and for carboxylic acid activation in aqueous or mixed-solvent systems; in studies on low racemization in peptides, it is more suitable as a supplementary control for different media conditions or alternative activation routes.
Oxime-type low-epimerization additive	3849-21-6	E138773	Ethyl (hydroxyimino)cyanoacetate	≥98%	A representative Oxyma-type additive, commonly used together with DIC, EDC, and related reagents; suitable as a modern additive option when screening conditions that balance coupling efficiency with suppression of epimerization.

Table 3 | Uronium Salts, Phosphonium Salts, and Other Coupling Reagents

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
HOAt-type uronium coupling reagent	148893-10-1	H109327	HATU	≥99%	A highly active uronium coupling reagent, commonly used for amino acid fragments with substantial steric hindrance or difficult coupling behavior; suitable for comparing coupling efficiency and epimerization control under highly active conditions.
Benzotriazole-type uronium coupling reagent	94790-37-1	H106174	HBTU	≥99%	One of the classic coupling reagents commonly used in Fmoc-SPPS; suitable for establishing a routine peptide-coupling baseline and comparing activity and side-reaction behavior against systems such as HATU, COMU, and TBTU.
Phosphonium coupling reagent	128625-52-5	P109336	1H-Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate	≥98%	This is PyBOP, commonly used in both solution-phase and solid-phase peptide coupling; suitable for comparing coupling efficiency and epimerization levels across different activation modes against systems such as HATU and HBTU.
Benzotriazinone-type low-epimerization coupling reagent	165534-43-0	D100524	3-(Diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one	≥98%	Known for relatively low epimerization, DEPBT is suitable for comparing coupling conditions involving stereochemically sensitive sites, sterically hindered substrates, or cases where configurational retention must be emphasized.
Chlorobenzotriazole-type uronium coupling reagent	330645-87-9	C106175	O-(6-Chlorobenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate	≥98%	This is HCTU, commonly used as an efficient uronium coupling reagent; suitable for parallel screening in routine solid-phase peptide synthesis alongside HBTU, HATU, and COMU.
Oxyma-type uronium coupling reagent	1075198-30-9	C340003	COMU	≥98%	A modern coupling reagent built around an Oxyma-derived leaving group, balancing activity, solubility, and configurational retention; suitable for establishing milder coupling conditions with relatively low epimerization.
Benzotriazole-type uronium coupling reagent	125700-67-6	T109338	TBTU	≥98%	The tetrafluoroborate analogue of HBTU, commonly used in routine peptide coupling and methodological comparisons; suitable for comparing practical performance differences arising from salt type against systems such as HBTU and HATU.
Phosphonium coupling reagent	56602-33-6	B106161	BOP Reagent	≥98%	A classical phosphonium coupling reagent, suitable for establishing a traditional high-activity coupling baseline and comparing side reactions and purity against newer phosphonium or uronium systems.
Control-type / alternative triazine coupling reagent	3945-69-5	D110326	4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride hydrate (DMTMM)	≥97%	A triazine-type coupling reagent commonly used for amide bond formation under relatively mild conditions; in studies on low racemization in peptides, it is more suitable as an alternative activation system for comparison with mainstream uronium, phosphonium, or carbodiimide–additive routes, especially when examining coupling behavior in different solvents or special media.
HOAt-type phosphonium coupling reagent	156311-83-0	A109335	(7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate	≥97%	This is PyAOP, commonly used in peptide couplings that demand both high activation efficiency and strong configurational retention; suitable for condition comparisons at high-risk sites against systems such as PyBOP, HATU, and DEPBT.

Table 4 | High-Risk Residue Monomers and Reagents Related to Side-Chain Protection

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Model residue monomer prone to epimerization	102410-65-1	F117102	Fmoc-Phg-OH	≥98.5%	Phenylglycine is a commonly used stereochemically sensitive model residue, suitable for amplifying differences in activation-stage epimerization and comparing the configurational retention ability of different coupling systems.
Histidine side-chain protected monomer	81379-52-4	F339404	Fmoc-L-His(Boc)-OH	≥98%	One of the commonly used protected histidine monomers, suitable for establishing baseline coupling conditions at His sites and for use as one of the screening substrates when studying how side-chain protecting modes influence configurational retention; its performance should be judged in combination with the specific activation system, base, temperature, and pre-activation conditions.
Aspartic acid side-chain protected monomer	71989-14-5	F116773	Fmoc-Asp(OtBu)-OH	≥98%	A commonly used protected monomer for Asp-sensitive sequences, suitable for screening the effects of deprotection base, temperature, and time on Asp-related side reactions.
Cysteine side-chain protected monomer	103213-32-7	F100409	Fmoc-Cys(Trt)-OH	≥98%	Cys is one of the typical high-risk residues in peptide synthesis, and this monomer is suitable for comparing how different coupling systems, pre-activation times, and temperatures affect configurational retention.
Histidine side-chain protected monomer	109425-51-6	F116780	Fmoc-His(Trt)-OH	≥98%	His is commonly used to evaluate the epimerization tendency of sensitive residues in different coupling systems; this monomer is suitable for parallel comparison with His(Boc)-based systems.
Cysteine side-chain protected monomer	86060-81-3	F116775	Fmoc-Cys(Acm)-OH	≥98%	A Cys monomer protected with Acm, suitable for comparing how different sulfur-protecting strategies affect coupling, downstream transformations, and configurational retention; commonly used in more refined Cys condition screening.
Reagent for extending protecting-group strategy	76-83-5	T106184	Trityl Chloride	≥97%	A classical reagent for introducing the Trt protecting group, useful for preparing Trt-protected derivatives of side chains such as those of Cys and His; suitable for extending protecting-group strategies, precursor design, or studies involving customized protection patterns.

Note: The above are representative Aladdin products. For more product specifications, please refer to the product list at the end of the article or search the Aladdin official website using the product name, CAS number, or catalog number.

References

[1] Duengo S, Muhajir MI, Hidayat AT, Musa WJA, Maharani R. Epimerisation in Peptide Synthesis. Molecules. 2023;28(24):8017.

[2] El-Faham A, Albericio F. Peptide Coupling Reagents, More than a Letter Soup. Chemical Reviews. 2011;111(11):6557-6602.

[3] Han Y, Albericio F, Barany G. Occurrence and Minimization of Cysteine Racemization during Stepwise Solid-Phase Peptide Synthesis. J Org Chem. 1997;62(13):4307-4312.

[4] Palasek SA, Cox ZJ, Collins JM. Limiting Racemization and Aspartimide Formation in Microwave-Enhanced Fmoc Solid-Phase Peptide Synthesis. J Pept Sci. 2007;13(3):143-148.

[5] Subirós-Funosas R, Prohens R, Barbas R, El-Faham A, Albericio F. Oxyma: An Efficient Additive for Peptide Synthesis to Replace the Benzotriazole-Based HOBt and HOAt with a Lower Risk of Explosion. Chemistry – A European Journal. 2009;15(37):9394-9403.

[6] Torikai K, Yanagimoto R, Watanabe LA. N(π)-2-Naphthylmethoxymethyl-Protected Histidines: Scalable, Racemization-Free Building Blocks for Peptide Synthesis. Org Process Res Dev. 2020;24(3):448-453.

[7] Hartrampf N, Saebi A, Poskus M, et al. Synthesis of Proteins by Automated Flow Chemistry. Science. 2020;368(6494):980-987.

[8] Fujiwara Y, Akaji K, Kiso Y. Racemization-free Synthesis of C-terminal Cysteine-Peptide Using 2-Chlorotrityl Resin. Chem Pharm Bull. 1994;42(3):724-726.

[9] Teruya K, Kawakami T, Aimoto S. Epimerization in Peptide Thioester Condensation. J Pept Sci. 2012;18(11):669-677.

[10] Szabó S, Szókán G, Khlafulla AM, Almás M, Kiss C, Rill A, Schön I. Configuration and racemization determination of cysteine residues in peptides by chiral derivatization and HPLC: application to oxytocin peptides. J Pept Sci. 2001;7(6):316-322. doi:10.1002/psc.325.

For more related articles, please see below:

A New Balance in Coupling Reagents: How DMT-TU Balances Reactivity, Racemization Control, and Thermal Hazard

Understanding ATD-DMAP: From Reagent Design to Esterification, Amidation, and Stereochemical Integrity

A Complete Guide to Choosing Resins for SPPS (Solid-Phase Peptide Synthesis): Fmoc/Boc Routes, C-Terminal Acid/Amide, and a Key-Parameter Navigator